DEVELOPMENT METHODOLOGY
Learn how the CMSV was developed.
References:
- Sully EA, Rosenberg JD, Tignor M, Geddes CE, Dilaverakis Fernandez A, Polis C. Adding It Up 2024: Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries. New York: Guttmacher Institute; 2025. doi:10.1363/2025.300735
- Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. Journal of the Royal Statistical Society: Series B. 2009;71(2):319–392.
- Lindström J, Kokko T, Enberg K, et al. Bayesian hierarchical modeling of catch-at-age data using a multinomial stick-breaking likelihood. ICES Journal of Marine Science. 2020;77(5):1810–1820.
- Bhatt S et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–211
- Couple-Years of Protection (CYP) | Global Health | Health Areas | Family Planning and Reproductive Health. U.S. Agency for International Development. Published December 4, 2023. Accessed September 1, 2023. https://www.usaid.gov/global-health/health-areas/family-planning/couple-years-protection-cyp
CMSV
HOME
INTERPRETATION
The CMSV provides estimates of two different types of contraceptive market size: 1) subnational region and district level users, and 2) national level private sector users, volume, and value of contraceptives.
READ MOREMETHODOLOGY
Using nationally representative surveys, routine health service data, and high-resolution population data, the subnational market size estimation serves to illustrate the distribution of contraceptive users and those with contraceptive needs.
READ MOREEXAMPLE USE CASES
How can policy makers, private sector actors, donors, non-governmental organizations, advocates, and researchers use the CMSV?
READ MOREContact us to learn how Metrics for Management can help you use targeted, accurate, and measurable data to expand and improve your services.
GET IN TOUCHAIMS Partners
The CMSV is a product of the Advancing Injectable Markets for Sustainability (AIMS) project which is led by PATH in partnership with the Africa Resource Centre, Health Systems Insight, Metrics for Management, and Solina Centre for International Development and Research. Dedicated to improving women's choice and access to injectable contraception, AIMS is creating a sustainable market for DMPA-SC and self-injection, ensuring balanced supply and demand, with robust public- and private-sector access to contraceptive injectables for women living in low- and middle-income countries. For more www.FPoptions.org | FPoptions@path.org.
Metrics for Management © 2026 |
in



